Evidence map›Paper›PMID 42375190›Full record

ArticleFrontiers in medicine2026

Regulatory Science: exploring an emerging scientific discipline in health care.

Laura Volpi, Michael D'Agosto, Tom Melvin, Barbara Sickmüller, Julian S Thimm

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laura VolpiHeidelberg University Hospital, Hospital Pharmacy, Heidelberg, Germany.
Michael D'AgostoFaculty of Engineering and Technology, Furtwangen University, Tuttlingen, Germany.
Tom MelvinInstitute for Clinical Trials, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland.
Barbara SickmüllerDeutsche Gesellschaft für Regulatorische Angelegenheiten e.V. (DGRA) - German Society of Regulatory Affairs, Bonn, Germany.
Julian S ThimmGMP and T Cell Therapy Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulatory Science has gained increasing prominence in the regulatory community, yet its character as a scientific discipline remains insufficiently clarified. While the term is widely used to describe activities that support regulatory decision-making, a unified normative anchoring is lacking. Existing definitions vary considerably in scope, often reflecting specific institutional contexts rather than a coherent scientific framework. This perspective examines Regulatory Science by reflecting on its scientific characteristics, intention, and potential contribution to effective regulation in the European health system. The article explores Regulatory Science as an emerging discipline by applying a humanity-based approach of conceptually scrutinizing its scientific core. By integrating insights from existing, non-congruent definitions, current activities, and regulatory practice, this perspective argues that Regulatory Science extends beyond compliance-oriented regulatory activities and product-specific assessment. Instead, it is positioned as a scientific approach to systematic, evidence-based reflection on regulatory systems, their functioning, and their further development in response to real market needs. Regulatory Science is proposed to provide the methodological foundation for meaningful regulation, consistent with its recitals that provide the objective for regulatory requirements. Based on this reflection, the article postulates conditions under which Regulatory Science can be justified as a distinct scientific discipline. It contributes to its further constitution in the scientific field through highlighting a required normative structure. This results in the proposal of a new, refined definition emphasizing regulation itself as the research objective, the need for scientific methodology, and its overall intention.

Indexed as

decision makingmedical device legislationpharmaceutical legislationpublic healthregulationscience

Identifiers

PMID42375190
PMCPMC13310879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.